Home

sparare condurre Contabilità oligomycin clinical use Dozzine Lungo pressione

Oligomycin - an overview | ScienceDirect Topics
Oligomycin - an overview | ScienceDirect Topics

Cancers | Free Full-Text | Inhibition of Alternative Cancer Cell Metabolism  of EGFR Mutated Non-Small Cell Lung Cancer Serves as a Potential Therapeutic  Strategy | HTML
Cancers | Free Full-Text | Inhibition of Alternative Cancer Cell Metabolism of EGFR Mutated Non-Small Cell Lung Cancer Serves as a Potential Therapeutic Strategy | HTML

IJMS | Free Full-Text | The Oligomycin-Sensitivity Conferring Protein of  Mitochondrial ATP Synthase: Emerging New Roles in Mitochondrial  Pathophysiology | HTML
IJMS | Free Full-Text | The Oligomycin-Sensitivity Conferring Protein of Mitochondrial ATP Synthase: Emerging New Roles in Mitochondrial Pathophysiology | HTML

Oligomycin A treatment compromises mitochondrial function in cultured... |  Download Scientific Diagram
Oligomycin A treatment compromises mitochondrial function in cultured... | Download Scientific Diagram

Oligomycin- Introduction and Mechanism of Action | Fermentek
Oligomycin- Introduction and Mechanism of Action | Fermentek

Oligomycin B | ATP Synthase Inhibitor | MedChemExpress
Oligomycin B | ATP Synthase Inhibitor | MedChemExpress

Electron Transport
Electron Transport

Targeting breast cancer metabolism with a novel inhibitor of mitochondrial  ATP synthesis | Oncotarget
Targeting breast cancer metabolism with a novel inhibitor of mitochondrial ATP synthesis | Oncotarget

High glycolytic activity of tumor cells leads to underestimation of  electron transport system capacity when mitochondrial ATP synthase is  inhibited | Scientific Reports
High glycolytic activity of tumor cells leads to underestimation of electron transport system capacity when mitochondrial ATP synthase is inhibited | Scientific Reports

Oligomycin - Wikipedia
Oligomycin - Wikipedia

Oligomycin | Cell Signaling Technology
Oligomycin | Cell Signaling Technology

High glycolytic activity of tumor cells leads to underestimation of  electron transport system capacity when mitochondrial ATP synthase is  inhibited | Scientific Reports
High glycolytic activity of tumor cells leads to underestimation of electron transport system capacity when mitochondrial ATP synthase is inhibited | Scientific Reports

Oligomycin-induced proton uncoupling - ScienceDirect
Oligomycin-induced proton uncoupling - ScienceDirect

Oligomycin A, ATP synthase inhibitor (CAS 579-13-5) (ab143423) | Abcam
Oligomycin A, ATP synthase inhibitor (CAS 579-13-5) (ab143423) | Abcam

PLOS ONE: Kinetic analysis of ATP hydrolysis by complex V in four murine  tissues: Towards an assay suitable for clinical diagnosis
PLOS ONE: Kinetic analysis of ATP hydrolysis by complex V in four murine tissues: Towards an assay suitable for clinical diagnosis

Oligomycin A | CAS 579-13-5 | Cayman Chemical | Biomol.com
Oligomycin A | CAS 579-13-5 | Cayman Chemical | Biomol.com

Application of mitochondrial inhibitors oligomycin, FCCP and antimycin... |  Download Scientific Diagram
Application of mitochondrial inhibitors oligomycin, FCCP and antimycin... | Download Scientific Diagram

Oligomycins-oxidative Phosphorylation Inhibitor - Creative Biolabs
Oligomycins-oxidative Phosphorylation Inhibitor - Creative Biolabs

Oligomycin A Datasheet
Oligomycin A Datasheet

Oligomycin A Datasheet
Oligomycin A Datasheet

Mitochondrial dysfunction induces the invasive phenotype, and cell  migration and invasion, through the induction of AKT and AMPK pathways in  lung cancer cells
Mitochondrial dysfunction induces the invasive phenotype, and cell migration and invasion, through the induction of AKT and AMPK pathways in lung cancer cells

Monitoring of dynamic ATP level changes by oligomycin-modulated ATP  synthase inhibition in SW480 cancer cells using fluorescent “On-Off”  switching DNA aptamer | SpringerLink
Monitoring of dynamic ATP level changes by oligomycin-modulated ATP synthase inhibition in SW480 cancer cells using fluorescent “On-Off” switching DNA aptamer | SpringerLink

The ATP synthase inhibition induces an AMPK-dependent glycolytic switch of  mesenchymal stem cells that enhances their immunotherapeutic potential
The ATP synthase inhibition induces an AMPK-dependent glycolytic switch of mesenchymal stem cells that enhances their immunotherapeutic potential